Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSI
Status:
Terminated
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
Under conditions of first-line drug treatment in antidiabetic drug naïve/drug free patients
with type 2 diabetes mellitus and dyslipidemia, to show that :- the efficacy of a fixed
combination (FC) of fenofibrate and metformin on glycemic control is not inferior to that of
rosiglitazone and the efficacy of FC of fenofibrate and metformin on triglyceride control is
superior to that of rosiglitazone.